Regulatory & Legal

A new intraoperative MRI gives surgeons real-time vision, promising more precise and safer glioma removal as it moves toward the competitive U.S. market.

A new patent for a compact quantum atomic clock could revolutionize navigation and defense, placing Quantum X Labs in a high-stakes race for GPS independence.

A new company, born from 15 years of military collaboration, emerges to redefine air and space power with advanced, drop-in propellants for U.S. forces.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.

A new, independently validated study proves a curated digital health network can slash healthcare costs and improve outcomes, setting a new bar for ROI.

With a decade of international experience, Knighthead Life launches its Chartline annuities, promising transparency in a booming U.S. retirement market.

A new testing platform from Armatus Bio aims to break a major bottleneck in gene therapy, promising faster paths to cures for rare neuromuscular diseases.

CredFin's 'Fund Your Freedom' campaign links patriotism to profit, but the CEO's past regulatory history casts a shadow over its ambitious promises.

NuCube Energy brings advanced microreactors to Arizona, aiming to solve the state's power crisis fueled by booming data center and chip manufacturing demands.

NerdWallet's annual awards are out, with Truist taking top honors. Discover how data and new trends are shaping the list of best mortgage lenders.

With a new broker-dealer license, Trafalgar is building a one-stop financial shop for Mexico's booming SME sector, fueled by nearshoring tailwinds.

A new Incline Village store combines fire-retardant tech, construction, and lumber expertise to empower residents against the growing threat of wildfires.

With its Juveena hydrogel pending FDA approval, Rejoni brings in a commercialization expert to tackle the underserved market for intrauterine adhesions.

This family law firm topped U.S. News's list by defying industry norms of burnout, proving a people-first culture leads to client and company success.

XPRIZE's new report reveals a $31B impact, proving its model creates lasting ventures and market disruption long after competitions end.

GRIN Therapeutics expands its pivotal Phase 3 study for radiprodil to Europe, fueling hope for a first-ever targeted therapy for a rare neurological disorder.

A tribally owned firm lands a massive defense contract, boosting U.S. military readiness and funneling vital economic support to the CSKT community.

In a landmark deal, Ecobat exits the European lead market, selling key assets to Clarios to focus on North America's booming advanced battery recycling sector.

Thousands march in 70+ cities for the Save Soil movement, pushing soil health from an environmental concern to a global security and climate priority.

Fueled by its revitalized Tyra hub, BlueNord reports historic production, proposing a massive dividend and cementing its role in European energy security.